1. Hong Kong Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Natural Beauty Bio-Technology Limited

Natural Beauty Bio-Technology Limited

NBBTF
Natural Beauty Bio-Technology LimitedUS flagOther OTC
0.06
USD
-NaN
- -
122.13MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.22
0.25
0.25
0.24
0.2
0.18
0.22
0.21
0.24
0.17
0.17
0.18
0.27
Basic EPS, GAAP
0.03
0.04
0.07
0.07
0.05
0.01
0.01
- -
0.02
-0.02
-0.01
-0.05
0.01
Free Cash Flow per Basic Share
0.04
0.07
0.04
0.05
-0.01
0.01
-0.03
-0.02
- -
-0.02
-0.02
-0.03
-0.04
Dividend per Share
0.01
0.04
0.07
0.1
0.08
0.05
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.2
0.2
0.2
0.18
0.14
0.11
0.1
0.1
0.1
0.13
0.12
0.07
0.07
Tangible Book Value per Share
0.37
0.37
0.33
0.29
0.29
0.23
0.26
0.28
0.31
0.29
0.27
0.22
0.24
Basic Weighted Avg Shares
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
2,002
Sales/Revenue/Turnover
439
506
507
475
400
370
438
411
488
336
336
354
539
Operating Margin (%)
16.69
25.42
31.41
36.36
36.76
9.45
8.52
1.2
8.9
-7.24
-1.6
-14.79
4.8
Depreciation Expense
40
39
34
24
22
26
31
37
35
34
27
32
39
Net Income, GAAP
58
71
137
148
105
26
22
8
35
-30
-15
-104
11
Effective Tax Rate (%)
29.61
38.52
19.7
24.37
28.18
32.94
40.79
13.64
27.23
- -
- -
- -
10.45
Profit Margin (%)
13.26
14.13
26.99
31.23
26.37
7.11
5
1.89
7.23
-9.07
-4.5
-29.3
1.96
Working Capital
487
505
466
403
376
222
202
196
212
114
60
101
35
LT Debt
- -
- -
- -
- -
- -
- -
31
16
34
24
15
138
132
Total Equity
788
774
733
655
651
552
568
611
658
597
575
448
474
Return on Invested Capital (%)
6.56
9.71
16.3
17.94
15.27
3.74
3.68
0.64
4.19
- -
- -
- -
3.17
Return on Capital (%)
15.06
17.88
34.63
39.95
33.23
10.57
9.73
3.48
12.11
- -
- -
- -
4.91
Return on Common Equity (%)
15.1
17.88
34.63
39.95
33.23
10.57
10.6
3.87
17.61
-13.39
-6.12
-55.25
7.5

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.75%
-4.32%
5.9%
Free Cash Flow
-135.49%
-121.07%
52.41%
Net Income, GAAP
41.64%
118.64%
-110.21%
Sales/Revenue/Turnover
2.79%
9.06%
52.36%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
336
2024
- -
- -
- -
- -
354
2025
- -
- -
- -
- -
539

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
-0.05
2025
- -
- -
- -
- -
0.01

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Chi Chung Cheng
Full Time Employees
597
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
Hopewell Centre Wan Chai Hong Kong
IPO Date
Feb 3, 2012
Website
ir-cloud.com
Similar Companies
OMNI Health, Inc. (OMHE)
Asian Phytoceuticals Public Co. Ltd. (APCO.BK)
Shiseido Company, Limited (SSDOY)
Amorepacific Corporation (090435.KS)
Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
Mason Group Holdings Limited (0273.HK)
Business
Natural Beauty Bio-Technology Limited (HKSE:157; OTC:NBBTF), an investment holding company established in 1976 and headquartered in Causeway Bay, Hong Kong, manufactures and sells skin care, beauty, aroma-therapeutic and make-up products, as well as health supplements under the Natural Beauty brand; it also provides skin treatments, beauty and spa services including hydrotherapy, facial treatments and body care, medical cosmetology services, skin care consulting, beauty training and beauty apparatus. The company operates over 2,000 outlets worldwide, primarily through franchise and self-owned channels serving Mainland China, Taiwan, Hong Kong, Macau, Southeast Asia including Malaysia, and other international markets; its product lines encompass salon-grade and over-the-counter skincare, essential oils and nutritional supplements developed via proprietary biotechnology research centers in Shanghai and Taipei. In 2025, the group reports interim profit surging 136% to HK$11 million driven by 70% turnover growth to over HK$260 million, fueled by Mainland China's 101% revenue increase to HK$220 million, addition of 237 new franchise stores (up 88%), strong performance in self-owned channels and health supplements (up 110% to HK$28 million), alongside its strategic partnership with Spain's INDIBA integrating advanced AI-enabled devices with proprietary formulations to launch the bestselling White Moonlight product series under its 'AI Technology, Beauty Industry, Holistic Health' strategy.